http://www.pharmaceutical-technology.com/news/accord-commercialise-hipra-covid-19-vaccine-uk/
0
0
8/4/23 at 12:28pm
Organization
Pharmaceutical Technology
Author
Phalguni Deswal
39 words
0
Comments
Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently said it seeks vaccines designed against XBB 1.5 Omicron.
You are the first to view
Create an account
or login to join the discussion